SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Andre Menache, Anne Beuter, Commentary: Lessons from the Analysis of Non-human Primates for Understanding Human Aging and Neurodegenerative Diseases, Frontiers in Human Neuroscience, 2016, 10,

    CrossRef

  2. 2
    Karim Fifel, Hugh Piggins, Tom Deboer, Modeling sleep alterations in Parkinson's disease: How close are we to valid translational animal models?, Sleep Medicine Reviews, 2016, 25, 95

    CrossRef

  3. 3
    Ainars Stepens, Pille Taba, Neuropathology of Drug Addictions and Substance Misuse, 2016,

    CrossRef

  4. 4
    Alevtina D. Zharikov, Jason R. Cannon, Victor Tapias, Qing Bai, Max P. Horowitz, Vipul Shah, Amina El Ayadi, Teresa G. Hastings, J. Timothy Greenamyre, Edward A. Burton, shRNA targeting α-synuclein prevents neurodegeneration in a Parkinson’s disease model, Journal of Clinical Investigation, 2015, 125, 7, 2721

    CrossRef

  5. 5
    Romina Aron Badin, Marta Vadori, Emanuele Cozzi, Philippe Hantraye, Translational research for Parkinson׳s disease: The value of pre-clinical primate models, European Journal of Pharmacology, 2015, 759, 118

    CrossRef

  6. 6
    Scott C. Vermilyea, Marina E. Emborg, α-Synuclein and nonhuman primate models of Parkinson's disease, Journal of Neuroscience Methods, 2015, 255, 38

    CrossRef

  7. 7
    Susan H. Fox, Jonathan M. Brotchie, Tom M. Johnston, Movement Disorders, 2015,

    CrossRef

  8. 8
    Rosa Giráldez-Pérez, Mónica Antolín-Vallespín, María Muñoz, Amelia Sánchez-Capelo, Models of α-synuclein aggregation in Parkinson’s disease, Acta Neuropathologica Communications, 2014, 2, 1, 176

    CrossRef

  9. 9
    Javier Blesa, Serge Przedborski, Parkinson’s disease: animal models and dopaminergic cell vulnerability, Frontiers in Neuroanatomy, 2014, 8,

    CrossRef

  10. 10
    Meera Saxena, Animal Models for Huntington's and Parkinson's Diseases, Materials and Methods, 2013, 3,

    CrossRef

  11. 11
    Erwan Bezard, Zhenyu Yue, Deniz Kirik, Maria Grazia Spillantini, Animal models of Parkinson's disease: Limits and relevance to neuroprotection studies, Movement Disorders, 2013, 28, 1
  12. 12
    Dominic J. Hare, Paul A. Adlard, Philip A. Doble, David I. Finkelstein, Metallobiology of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine neurotoxicity, Metallomics, 2013, 5, 2, 91

    CrossRef

  13. 13
    Jiro Kasahara, Mohammed Emamussalehin Choudhury, Hironori Yokoyama, Naoto Kadoguchi, Masahiro Nomoto, Animal Models for the Study of Human Disease, 2013,

    CrossRef

  14. 14
    Javier Blesa, Sudarshan Phani, Vernice Jackson-Lewis, Serge Przedborski, Classic and New Animal Models of Parkinson's Disease, Journal of Biomedicine and Biotechnology, 2012, 2012, 1

    CrossRef

  15. 15
    Ilse S. Pienaar, Bingwei Lu, Timothy Schallert, Closing the gap between clinic and cage: Sensori-motor and cognitive behavioural testing regimens in neurotoxin-induced animal models of Parkinson's disease, Neuroscience & Biobehavioral Reviews, 2012, 36, 10, 2305

    CrossRef

  16. 16
    J. Bové, C. Perier, Neurotoxin-based models of Parkinson's disease, Neuroscience, 2012, 211, 51

    CrossRef

  17. You have free access to this content17
    Susan Duty, Peter Jenner, Animal models of Parkinson's disease: a source of novel treatments and clues to the cause of the disease, British Journal of Pharmacology, 2011, 164, 4
  18. 18
    Gaynor Smith, E Murphy, Stephen Dunnett, Emma Lane, Handbook of Laboratory Animal Science, Volume II, Third Edition, 2011,

    CrossRef

  19. 19
    Stanley Fahn, Joseph Jankovic, Mark Hallett, Principles and Practice of Movement Disorders, 2011,

    CrossRef

  20. 20
    Kurt A. Jellinger, Youmans Neurological Surgery, 2011,

    CrossRef

  21. 21
    Tom H. Johnston, Emma L. Lane, Pathophysiology, Pharmacology, and Biochemistry of Dyskinesia, 2011,

    CrossRef

  22. 22
    Susan H. Fox, Jonathan M. Brotchie, Recent Advances in Parkinson’S Disease - Translational and Clinical Research, 2010,

    CrossRef

  23. 23
    Peter Jenner, From the MPTP-treated primate to the treatment of motor complications in Parkinson's disease, Parkinsonism & Related Disorders, 2009, 15, S18

    CrossRef

  24. 24
    C. Warren Olanow, Jeffrey H. Kordower, Modeling Parkinson's disease, Annals of Neurology, 2009, 66, 4